TVARDI THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TVARDI THERAPEUTICS, INC. (TVRD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 31.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 31.00K shares, a 92.21% decline year-over-year.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 294.75K shares.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 105.50K shares.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 2.00K shares.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 505.44K shares, a 14978.76% increase from fiscal 2024.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.35K shares, a 99.83% decline from fiscal 2023.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.00M shares, a 5.51% increase from fiscal 2022.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.90M shares, a 33.54% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 31.00K shares 10-Q · filed 2026-08-14 | 325.75K shares 10-Q · filed 2026-08-14 | 431.25K shares derived: sum of 3 quarters · filed 2026-08-14 | 433.25K shares derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | 294.75K shares 10-Q · filed 2026-05-08 | 400.25K shares derived: sum of 2 quarters · filed 2026-05-08 | 402.25K shares derived: sum of 3 quarters · filed 2026-05-08 | 800.19K shares derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | 105.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 107.50K shares derived: sum of 2 quarters · filed 2026-03-31 | 505.44K shares derived: sum of 3 quarters · filed 2026-08-14 | 505.44K shares 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 2.00K shares 10-Q · filed 2025-11-13 | 399.94K shares derived: sum of 2 quarters · filed 2026-08-14 | 399.94K shares 10-Q · filed 2025-11-13 | 399.94K shares derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | 397.94K shares 10-Q · filed 2026-08-14 | 397.94K shares 10-Q · filed 2025-08-14 | 397.94K shares derived: sum of 3 quarters · filed 2026-08-14 | 397.94K shares derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-31 | 3.35K shares 10-K · filed 2026-03-31 | 253.76K shares 10-K · filed 2025-03-11 | ||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-13 | 3.35K shares 10-Q · filed 2025-11-13 | 3.05M shares 10-Q · filed 2024-11-14 | 1.93M shares derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | 3.35K shares 10-Q · filed 2025-08-14 | 3.05M shares 10-Q · filed 2024-08-14 | 1.93M shares derived: sum of 3 quarters · filed 2025-08-14 | 2.08M shares derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 1.88M shares 10-Q · filed 2024-05-13 | 1.93M shares derived: sum of 2 quarters · filed 2024-05-13 | 2.08M shares derived: sum of 3 quarters · filed 2024-05-13 | 2.43M shares derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2023-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | 205.75K shares derived: sum of 2 quarters · filed 2024-03-06 | 555.51K shares derived: sum of 3 quarters · filed 2024-03-06 | 2.00M shares 10-K · filed 2024-03-06 | |||
| 2023-09-30 | 155.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 505.51K shares derived: sum of 2 quarters · filed 2023-11-13 | 1.95M shares 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | 349.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 1.80M shares 10-Q · filed 2023-08-07 | |||||
| 2023-03-31 | 1.45M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 1.90M shares 10-K · filed 2023-03-06 | ||||||
| 2021-12-31 | 1.42M shares 10-K · filed 2022-03-01 | ||||||
| 2020-12-31 | 1.38M shares 10-K · filed 2021-02-25 | ||||||
| 2019-12-31 | 1.32M shares 10-K · filed 2020-02-27 | ||||||
| 2018-12-31 | 1.20M shares 10-K · filed 2020-02-27 | ||||||
| 2017-12-31 | 1.33M shares 10-K · filed 2020-02-27 | ||||||
| 2016-12-31 | 1.08M shares 10-K · filed 2019-03-12 | ||||||
| 2015-12-31 | 774.00K shares 10-K · filed 2018-03-15 | ||||||
| 2014-12-31 | 230.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | 270.00K shares derived: sum of 2 quarters · filed 2017-03-10 | 497.00K shares derived: sum of 3 quarters · filed 2017-03-10 | 884.00K shares 10-K · filed 2017-03-10 | |||
| 2014-09-30 | 40.00K shares 10-Q · filed 2014-11-10 | 267.00K shares derived: sum of 2 quarters · filed 2014-11-10 | 654.00K shares 10-Q · filed 2014-11-10 | 654.00K shares derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2014-06-30 | 227.00K shares 10-Q · filed 2014-08-07 | 614.00K shares 10-Q · filed 2014-08-07 | 614.00K shares derived: sum of 3 quarters · filed 2016-03-11 | 614.00K shares derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2014-03-31 | 387.00K shares 10-Q · filed 2014-05-12 | 387.00K shares derived: sum of 2 quarters · filed 2016-03-11 | 387.00K shares derived: sum of 3 quarters · filed 2016-03-11 | 387.00K shares derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-11 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-11 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-10 | 0.00 shares 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-07 | 0.00 shares 10-Q · filed 2014-08-07 | |||||
| 2013-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |